Shabir Madhi to Respiratory Syncytial Virus Vaccines
This is a "connection" page, showing publications Shabir Madhi has written about Respiratory Syncytial Virus Vaccines.
Connection Strength
2,641
-
Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine. Obstet Gynecol. 2025 Feb 01; 145(2):147-156.
Score: 0,958
-
Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. N Engl J Med. 2020 07 30; 383(5):426-439.
Score: 0,705
-
Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial. Obstet Gynecol. 2025 Feb 01; 145(2):157-167.
Score: 0,240
-
Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial. J Infect Dis. 2023 08 11; 228(3):299-310.
Score: 0,217
-
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. N Engl J Med. 2023 Apr 20; 388(16):1451-1464.
Score: 0,212
-
Global Respiratory Syncytial Virus-Related Infant Community Deaths. Clin Infect Dis. 2021 09 02; 73(Suppl_3):S229-S237.
Score: 0,190
-
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children. J Infect Dis. 2004 Dec 15; 190(12):2096-103.
Score: 0,059
-
The dawn of preventing respiratory syncytial virus lower respiratory tract infections in children S Afr Med J. 2024 10 08; 114(10):e2582.
Score: 0,059